Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
When carrying out clinical trials within the European Union (EU) using Investigational Medicinal Products (IMPs) that have been manufactured and/or tested outside the EU, there is a requirement for a Qualified Person (QP) to sign a "QP Declaration" stating that IMPs have been manufactured according to standards of Good Manufacturing Practice (GMP) at least equivalent to those applied in the EU.
Download this fact sheet to learn how our team of QPs bring extensive experience across a wide range of dosage forms including aerosols, biologicals, creams, liquids, ointments, solids, sterile products and novel drug delivery systems.